DIAGMMR® -
DIAGNOSTICS INNOVATION

OUR MISSION IS TO SAVE LIVES THROUGH THE EARLY DETECTION OF LYNCH SYNDROME
WITH AN EASY AND ACCURATE DIAGNOSTIC METHOD.

LYNCH SYNDROME

One of the main single causes of colorectal and endometrial cancers, Lynch syndrome, i.e. inherited mismatch repair (MMR) deficiency, is carried by up to 1/279 of the population*.

INHERITED DEFECT

Lynch syndrome (LS) is inherited with 50% probability within affected families. Each year, there are 3.5 million new cancer cases within LS spectrum.

INDIVIDUAL RISK

Individuals with inherited MMR deficiency have more than 70% risk of developing colorectal cancer, compared to 2% in the general population on a global scale.

INNOVATIVE SOLUTION

The DiagMMR® method developed by LS CancerDiag Ltd is a non-invasive test to detect LS carriers, enabling preventive care and helping save lives.